MDS MPD

Question 1

abnormal development of cell on bm

Answer 1

dysplasia

Question 2

cytopenia of one or more cell line

Answer 2

myelodysplastic syndrome

Question 3

cytosis of all cell line

Answer 3

myeloproliferative syndrome

Question 4

the proliferation outpaces apoptosis

Answer 4

myeloproliferatve disorder

Question 5

results from clonal abnormalities of hematopoietic pluripotent stem cell

Answer 5

myelodysplastic syndrome

Question 6

known to be pre leukemias

Answer 6

myelodysplastic syndrome

Question 7

target age of myelodysplastic syndrome

Answer 7

50-70

Question 8

peripheral blood of mds

Answer 8

cytopenia

Question 9

myeloid cell line of MDS

Answer 9

dysplastic

Question 10

MDS- ACUTE LEUKEMIA

Answer 10

1 YEAR

Question 11

ACUTE LEUKEMIA TO STAGE 1

Answer 11

MONTHS

Question 12

ABNORMAL RBC PRODUCTION LEADING TO MDS

Answer 12

DYSERYTHROPOIESIS

Question 13

ABNORMAL PRODUCTION OF WBSC

Answer 13

DYSMYELOPOIESIS

Question 14

PERSISTENCE OF BASOPHILIA IN THE CYTOPLASM

Answer 14

DYSMYELOPOIESIS

Question 15

PRESENCE OF MICRO AND MACRO CELLS

Answer 15

DIMORPHIC RBC POPULATION

Question 16

MORPHOLOGY OF RBC HAVING VIT 12 DEF AND FOLATE DEFICIENCY

Answer 16

OVAL MARCROCYTE

Question 17

MORPHOLOGIC FEATURE IF HB NOT COMPLETED

Answer 17

HYPOCHROMIC MICROCYTE

Question 18

ABNORMAL PRODUCTION OF MEGAKARYOCYTE

Answer 18

DYSMEGAKARYPOIESIS

Question 19

SHEDS OF TO BECOME PLT

Answer 19

MEGAKARYOCYTE

Question 20

2 TYPES OF MDS

Answer 20

PRIMARY MDS
THERAPY RELATED MDS

Question 21

PRIMARY MDS

Answer 21

1. ENVIRONMENTAL EXPOSURE
2. MUTATION CAUSED BY CHEMICAL, RADIATION , VIRAL INFECTION OR SMOKING
3. GENETIC INHERITANCE OF HEMATOLOGIC DISORDER

Question 22

CLASSIFICATION OF MDS RELIES ON MORPHOLOGY

Answer 22

FAB

Question 23

FAB CLASSIFICATION

Answer 23

RELIES ON MORPHOLOGY
DOES NOT ADDRESS THERAPY RELATED OR HEREDITARY FORMS
DOES NOT CONSIDER CHILDHOOD MDS

Question 24

WHO CLASSIFICATION

Answer 24

RETAINS FAB FEATURES
RECOGNIZE MOLECULAR, CYTOGENETIC AND IMMUNOLOGIC CHARACTERISTIC
REMOVE CATEGORIES OF CMML AND RAEB-T

Question 25

3 TYPES REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLSIA

Answer 25

1. REFRACTORY ANEMIA 2. REFRACTORY NEUTROPENIA 3. REFRACTORY THROMBOCYTOPENIA

Question 26

RCUD PROGNOSIS PROGRESSION

Answer 26

5 YEARS PROGNOSIS 6 % PROGRESSION

Question 27

MDS-RS-SLD PROGNOSIS PROGRESSION

Answer 27

5 YEARS 2 %

Question 28

MDS-RS-MLD PROGNOSIS PROGRESSION

Answer 28

33 MONTHS 11 %

Question 29

MDS EB2 PROGNOSIS PROGRESSION

Answer 29

<2 YEARS 33 %

Question 30

MDS EB1 PROGNOSIS PROGRESSION

Answer 30

< 2 YEARS 25 %

Question 31

MDS ASSOCIATED WITH DEL (5Q)

Answer 31

9 MONTHS RARE OR NO

Question 32

GENE THAT CONTRIBUTE TO THE SEVERITY OF MDS-RS-SLD

Answer 32

SF3B1

Question 33

HOW MANY % ARE THERE IN CASES OF RARS?

Answer 33

80 %

Question 34

+ AUER RODS

Answer 34

MDS EB2

Question 35

WHAT CHROMOSOME IS MISSING IN MDS ASSOCIATED W ISOLATED DEL 5Q

Answer 35

CHROMOSOME 5

Question 36

OCCURS MOST ON OLDER WOMEN

Answer 36

MDS ASSOCIATED WITH ASSOCIATED WITH DEL 5Q

Question 37

LACKS SPECIFIC NECESSARY CLASSIFICATIONS

Answer 37

MYELODYSPLASTIC SYNDROME

Question 38

KNOWN A DENOVO MDS

Answer 38

CHILDHOOD MDS

Question 39

RAEBIT

Answer 39

REFRACTORY ANEMIA WITH EXCESS BLAST IN TRANSFORMATION

Question 40

PERIPHERAL BLOOD PERCENTAGE IN FAB CASSIFICATION

Answer 40

5 %

Question 41

BM PERCENTAGE IN FAB CASSIFICATION

Answer 41

20-30 %

Question 42

AUER ROD +

Answer 42

FAB CLASSIFICATION